About Us
Advance Innovation with Visionary Leaders
The Mehling Family Office was founded by Dr. Brian Mehling along with his siblings, with a dedicated mission to promote regenerative medicine and stem cell technology. Their focus extends beyond the advancement of these cutting-edge fields to ensuring that these innovations are accessible to underserved populations. By supporting research, development, and the practical application of these medical technologies, the Mehling Family Office aims to support innovation in regenerative medicine and expand access to promising research for communities that lack adequate medical resources.
Their efforts are driven by a commitment to both scientific excellence and social responsibility. The Mehling Family Office seeks to help connect promising research with the people who could benefit, recognizing that the potential benefits of regenerative medicine and stem cell science should not be limited to those with easy access to healthcare.
In addition to funding and supporting groundbreaking research, the Mehling Family Office is actively involved in initiatives that bring these medical advancements to practical use. This includes collaborations with healthcare providers, academic institutions, and other organizations that share their vision of a more equitable healthcare system. They are dedicated to not only advancing scientific knowledge but also to supporting efforts that bring that knowledge closer to the people who could benefit.
The office’s initiatives also encompass educational programs and community outreach, aimed at raising awareness about the potential of regenerative medicine and stem cell therapies. By educating both the public and healthcare professionals, they hope to foster a broader understanding of this innovative research.
Through their comprehensive approach, the Mehling Family Office is making significant strides in the field of regenerative medicine, ensuring that the benefits of these advancements are felt by all, regardless of socio-economic status. Their work embodies a blend of pioneering scientific research, responsible investment, and a deep commitment to social equity, setting a powerful example of how medical innovation can be supported for the greater good.
